Cost-utility analysis of cerebrospinal fluid versus blood biomarkers for early detection of Alzheimer's disease and mild cognitive impairment in Thailand: a modeling study
Leelahavarong P., Prawjaeng J., Angkab P., Wongkom N., Scheltens P., Srinonprasert V., Senanarong V. Cost-utility analysis of cerebrospinal fluid versus blood biomarkers for early detection of Alzheimer's disease and mild cognitive impairment in Thailand: a modeling study. BMC Health Services Research Vol.26 No.1 (2026). doi:10.1186/s12913-026-14405-5 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/116927
Title
Cost-utility analysis of cerebrospinal fluid versus blood biomarkers for early detection of Alzheimer's disease and mild cognitive impairment in Thailand: a modeling study